Superoxide Dismutase 1 Folding Stability as a Target for Molecular Tweezers in SOD1‐Related Amyotrophic Lateral Sclerosis

• Published in: Chembiochem : a European journal of chemical biology 2022-11, Vol.23 (21), p.e202200396-n/a
• Main Authors: Samanta, Nirnay, Ruiz‐Blanco, Yasser B., Fetahaj, Zamira, Gnutt, David, Lantz, Carter, Loo, Joseph A., Sanchez‐Garcia, Elsa, Ebbinghaus, Simon
• Format: Article
• Language: English
• Subjects: Agglomeration; Alzheimer's disease; Amyotrophic lateral sclerosis; Amyotrophic Lateral Sclerosis - genetics; Amyotrophic Lateral Sclerosis - metabolism; BASIC BIOLOGICAL SCIENCES; Binding sites; Biocompatibility; CLR01; Drug development; Free energy; Humans; Huntington's disease; Huntingtons disease; INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY; Lateral stability; Ligands; Lysine; Mass spectrometry; Mass spectroscopy; medicinal chemistry; Modulation; Molecular dynamics; Molecular modelling; Movement disorders; Mutation; Neurodegenerative Diseases; Parkinson's disease; Protein Folding; Proteins; SOD1; Superoxide dismutase; Superoxide Dismutase - metabolism; Superoxide Dismutase-1 - chemistry; Superoxide Dismutase-1 - genetics; Superoxide Dismutase-1 - metabolism; supramolecular ligands; Toxicity
• ISSN: 1439-4227; 1439-7633
• DOI: 10.1002/cbic.202200396

Protein misfolding and aggregation are hallmarks of many severe neurodegenerative diseases including Alzheimer's, Parkinson's and Huntington's disease. As a supramolecular ligand that binds to lysine and arginine residues, the molecular tweezer CLR01 was found to modify the aggregation pathway of disease‐relevant proteins in vitro and in vivo with beneficial effects on toxicity. However, the molecular mechanisms of how tweezers exert these effects remain mainly unknown, hampering further drug development. Here, we investigate the modulation mechanism of unfolding and aggregation pathways of SOD1, which are involved in amyotrophic lateral sclerosis (ALS), by CLR01. Using a truncated version of the wildtype SOD1 protein, SOD1bar, we show that CLR01 acts on the first step of the aggregation pathway, the unfolding of the SOD1 monomer. CLR01 increases, by ∼10 °C, the melting temperatures of the A4V and G41D SOD1 mutants, which are commonly observed mutations in familial ALS. Molecular dynamics simulations and binding free energy calculations as well as native mass spectrometry and mutational studies allowed us to identify K61 and K92 as binding sites for the tweezers to mediate the stability increase. The data suggest that the modulation of SOD1 conformational stability is a promising target for future developments of supramolecular ligands against neurodegenerative diseases. The molecular tweezer CLR01 binds specifically to lysine residues of superoxide dismutase 1 (SOD1) and thereby increases its folding stability.